British drug companies are making a new assault on schizophrenia, with about 16 novel medicines in the pipeline. A number of experimental drugs are designed to alter the chemistry of brain regions ...

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric ...

The global schizophrenia drug market size was US$ 7.9 billion in 2021. The global schizophrenia drug market is forecast to grow to US$ 9.8 billion by 2030, registering a compound annual growth rate ...

Atypical antipsychotic drugs have been shown to be more efficacious in treating cognitive disturbances of schizophrenia compared with typical antipsychotic drugs. Serotonin (5-hydroxytryptamine [5 ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...